Karlheinz Schmelig

Karlheinz Schmelig

Direktor/Vorstandsmitglied bei PROSTATYPE GENOMICS AB

Health Technology
Consumer Services
Finance

Ursprung des Netzwerks ersten Grades von Karlheinz Schmelig

EinheitArt der EinheitIndustrie
21
Private Company Investment Managers 21
Public Company Pharmaceuticals: Major 16
Public Company Pharmaceuticals: Major 15
12
Private Company Biotechnology 12
9
Holding Company Miscellaneous Commercial Services 9
8
Holding Company Pharmaceuticals: Generic 8
7
Subsidiary Pharmaceuticals: Major 7
6
Holding Company Medical Specialties 6
6
Holding Company Biotechnology 6

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Karlheinz Schmelig

UnternehmenSektorVerknüpfte PersonenHauptposition
BIOFRONTERA INC. Pharmaceuticals: Major

John Borer

Kevin Weber

Pamela Keck

Heikki Lanckriet

Director/Board Member

Director/Board Member

Investor Relations Contact

Director/Board Member

INSEAD College/University

Peter Neubeck

Yulia Butscheid

Marc Biel

Atanas Mukov

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Friedrich-Alexander University of Erlangen-Nuremberg College/University

Christoph Petry

Karin Lergenmüller

Lena Krzyzak

Graduate Degree

Doctorate Degree

Doctorate Degree

Pharmaceuticals: Major

Markus Hosang

Ulrich Granzer

Claus Kremoser

Director/Board Member

Director/Board Member

Chairman

Ruhr-Universität Bochum College/University

Wolfgang Kintzel

Aristotelis Nastos

Franca Ruhwedel

Graduate Degree

Graduate Degree

Doctorate Degree

Universität zu Köln College/University

Helge Lubenow

Andreas Schmidt

Markus Zumbansen

Doctorate Degree

Doctorate Degree

Doctorate Degree

Biotechnology

Wolfgang Kintzel

Joachim Rautter

Aristotelis Nastos

Chairman

Chairman

Chairman

Miscellaneous Commercial Services

Wolfgang Kintzel

Aristotelis Nastos

Chief Executive Officer

Director/Board Member

University of Freiburg College/University

Reinhard Eyring

Nicole Faust

Undergraduate Degree

Doctorate Degree

Pharmaceuticals: Major

Klaus Schollmeier

Ulrich Granzer

Corporate Officer/Principal

General Counsel

Pharmaceuticals: Major

Klaus Schollmeier

Peter Sondermann

Chief Executive Officer

Founder

SPARTA AG Investment Managers

Wilhelm Konrad Zours

Karin Lergenmüller

Chairman

Director/Board Member

Financial Conglomerates

Wilhelm Konrad Zours

Karin Lergenmüller

Corporate Officer/Principal

Chairman

Pharmaceuticals: Generic

Markus Hosang

Klaus Schollmeier

Director/Board Member

Chairman

Pharmaceuticals: Major

Aristotelis Nastos

Peter Neubeck

Director/Board Member

Chairman

Philipps University of Marburg College/University

Ulrich Granzer

Yulia Butscheid

Graduate Degree

Doctorate Degree

Swiss Federal Institute of Technology College/University

Markus Hosang

Peter H. Seeberger

Doctorate Degree

Corporate Officer/Principal

Eberhard Karls Universität Tübingen College/University

Ulrich Granzer

Jörgen Tielmann

Doctorate Degree

Graduate Degree

Textiles

Joachim Rautter

Aristotelis Nastos

Chief Investment Officer

Corporate Officer/Principal

Investment Managers

Lena Krzyzak

Alexander Ehlgen

Private Equity Analyst

Private Equity Investor

Investment Managers

Rainer Christine

John Yianni

Private Equity Investor

Private Equity Investor

Investment Managers

Christian Stein

Sebastian Puenzeler

Private Equity Investor

Private Equity Investor

University of Duisburg-Essen College/University

Aristotelis Nastos

Pawel Schapiro

Doctorate Degree

Undergraduate Degree

BAYER AG Pharmaceuticals: Major

Ulrich Granzer

Christoph Petry

General Counsel

Chief Tech/Sci/R&D Officer

Ludwig-Maximilians-Universität München College/University

Christian Leikert

Peter Neubeck

Masters Business Admin

Doctorate Degree

EPIGENOMICS AG Medical Specialties

Heikki Lanckriet

Helge Lubenow

Director/Board Member

Chairman

Biotechnology

Harald Poth

Thomas Hoffmann

Director/Board Member

Director/Board Member

2INVEST AG Financial Conglomerates

Heikki Lanckriet

María del Pilar de la Huerta Martínez

Chief Executive Officer

Chief Executive Officer

Investment Managers

Detlev Mennerich

Alexander Ehlgen

Private Equity Investor

Private Equity Investor

ROCHE HOLDING AG Pharmaceuticals: Major

Gerald Heinz Möller

Markus Hosang

Sales & Marketing

Corporate Officer/Principal

University of Stockholm College/University

Lidi Xu

Nicklas Rosendal

Graduate Degree

Undergraduate Degree

4BASEBIO PLC Biotechnology

Heikki Lanckriet

María del Pilar de la Huerta Martínez

Chief Executive Officer

Director/Board Member

Biotechnology

Andreas Schmidt

Dieter Trau

Chief Executive Officer

Founder

Investment Managers

Regina Hodits

Ulrich Granzer

Private Equity Investor

Private Equity Investor

Biotechnology

Christoph Petry

Chief Executive Officer

National University of Singapore College/University

Dieter Trau

Corporate Officer/Principal

The Hong Kong University of Science & Technology College/University

Dieter Trau

Doctorate Degree

PANAMAX AG Financial Conglomerates

Karin Lergenmüller

Chairman

HEIDELBERGER BETEILIGUNGSHOLDING AG Financial Conglomerates

Karin Lergenmüller

Director/Board Member

Packaged Software

Yulia Butscheid

Corporate Officer/Principal

Riverside Europe Partners GmbH Investment Managers

Christian Stein

Private Equity Investor

Kingstone Europe AG

Karin Lergenmüller

Chairman

Alpha Cleantec AG

Karin Lergenmüller

Chairman

MARNA BETEILIGUNGEN AG Financial Conglomerates

Karin Lergenmüller

Director/Board Member

8sens.biognostic GmbH

Dieter Trau

Founder

Information Technology Services

Marc Biel

Chief Executive Officer

Statistik

International

Deutschland 40
Schweiz 4
Vereinigte Staaten 3
Singapur 3
Frankreich 2

Sektoral

Health Technology 17
Consumer Services 14
Finance 13
Commercial Services 3
Technology Services 3

Operativ

Director/Board Member 240
Corporate Officer/Principal 79
Chairman 60
Private Equity Investor 58
Chief Executive Officer 46
  1. Börse
  2. Insiders
  3. Karlheinz Schmelig
  4. Unternehmensverbindungen